We always strive to do more in order to positively impact our patients consumers, employees, communities as well as our shareholders. We firmly believed that doing business with a conscience is integral in order to sustain our business success.
LATEST
29 FEBRUARY 2024
Pharmaniaga Berhad (Pharmaniaga) today announces the appointment of Zulkifli Jafar as its Executive Director, marking a pivotal move to navigate the turnaround of the Group, after the successful submission of Regularisation Plan to Bursa Malaysia within the stipulated timeline.
23 FEBRUARY 2024
Pharmaniaga Berhad announced today its significant step towards financial revitalisation by submitting the Regularisation Plan to Bursa Malaysia. This move marks a critical milestone by the Group to recover and enhance its financial standing, aiming to exit its Practice Note 17 (PN17) status.
29 NOVEMBER 2023
Pharmaniaga Berhad’s (Pharmaniaga) announces its plan to raise up to RM655 million to
bolster its financial position and revitalise financial health, marking a crucial step toward
exiting its Practice Note 17 (PN17) status.
11 AUGUST 2023
Pharmaniaga Berhad (Pharmaniaga) is embarking on an extensive business restructuring exercise
that includes implementing rigorous fiscal discipline initiatives across its operations as part of the
Group’s comprehensive recovery plan.
26 JULY 2023
Pharmaniaga Berhad (Pharmaniaga) and CSPC Pharmaceutical Group Limited (CSPC) of China
today forged a partnership on the research and development, manufacturing, and commercialisation
of innovative pharmaceutical and biopharmaceutical products.